Clinical Trial: Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase IIa, Open-label, Single-arm, Two Stage, Multi-centre Study to Investigate the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Repeated Subcutaneous Administration of BIM23B065 i

Brief Summary: The purpose of the protocol is evaluate the safety, the pharmacodynamics and the pharmacokinetic of repeated administration of BIM23B065 in subjects with acromegaly.